DNA decoy drug, first of its kind, trialled in resistant melanoma
A drug that mimics broken strands of DNA and pushes treatment-resistant cancer cells to autodestruct has produced encouraging results in a first clinical trial. The medicine, DT01, is the forerunner for a new class of drug developed by researchers at the Institut Curie in Paris...
Comment
Fertility services in the new NHS
by Mark Johnson
From next year, local GP-led Clinical Commissioning Groups will take on the commissioning responsibilities of Primary Care Trusts, with the latter due to be abolished in April 2013. This now includes responsibility for commissioning fertility services such as IVF treatment...
'Marry out?' Some surprising consequences of genetic disease risk among Ashkenazi Jews
by Dr Jessica Mozersky
Ashkenazi Jews have historically been an endogamous population. Marrying within the group remains important to many Jews because endogamy is seen as one way to preserve Judaism and ensure the survival of future generations. In the wake of the Holocaust, and amidst a steadily decreasing Jewish population, Jewish survival has great cultural relevance...